Molecular diagnostics, also called as MDx, is a branch of in vitro diagnostics
that helps in identification of nucleic acids. Molecular diagnostics assist in
identifying nucleic acids in foreign organisms or genetic markers of any
patient. MDx tests is the fastest growing branch of in vitro diagnostics and
its growth is influenced by factors such as rapid turnaround time, high
sensitivity, low cost and convenient workflow. It is a highly regulated area of
biotechnology and requires 510(k)/IVD clearance.

MDx employs different assays and platforms that are
paired with several technologies for identification of genetic variations. The
various technologies used in MDx are PCR, qPCR, TMA, FISH, capillary electrophoresis,
next-generation sequencing, and microarrays. The increase in the incidence of
chronic diseases, growth in aging population, availability of different types
of tests, and development in pharmacogenomics will be the major growth drivers
of this market.

The major segments of MDx market are therapeutics,
technology and analysis testing, test locations, and test foundation.
Geographically MDx market can be sub-segmented into North America, Asia
Pacific, Europe, and the Rest of the World. At present many corporate actions
such as mergers and acquisitions, strategic alliances and others are taking
place in this market which may positively affect the future market scenario.
The major competitors in the MDx market are biotechnology companies such as
Abbott, Roche Diagnostics, Myriad Genetics, Gen-Probe, Illumina, Cepheid, Life
Technologies, and some others.

This research report analyzes this market depending on
its market segments, major geographies, and current market trends. Geographies
analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World

This report provides comprehensive analysis
of

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

This report is a complete study of current trends in
the market, industry growth drivers, and restraints. It provides market
projections for the coming years. It includes analysis of recent developments
in technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed
value chain analysis.

Continuous glucose monitoring systems are real-time
monitoring systems for checking glucose levels in the body. The system consists
of a tiny sensor inserted under the skin to test glucose levels in the tissue
fluid. The sensor stays in place for several days to a week and then must be
replaced. A transmitter sends information about glucose levels via radio waves
from the sensor to a pager-like wireless monitor. The key advantage of
continuous glucose monitoring is that it can help identify fluctuations and
trends that would otherwise go unnoticed with standard HbA1c tests and
intermittent finger stick measurements.

Development in the multi-parameter mid-range patient
monitoring devices can create a new opportunity for further expansion. Collaboration
with established local companies can be helpful for manufacturers to provide
effective services and maintain profit margins simultaneously. Further cost
reduction by integration of continuous glucose monitors with insulin pumps can
be helpful for CGMs to achieve significant popularity among the price sensitive
Asian consumers.

The CGM systems market is a highly specialized niche
market; it can be further segmented into the market for transmitters-receivers
and the one for glucose. The U.S. is contributing the maximum in terms of the
total revenue earned from CGMs. The European market is still in a nascent stage
and contributes a small amount to the total revenue. The Asia-Pacific region
and Brazil also contribute very little to the global revenues. The CGM systems
markets in the U.S and Europe are growing at a fast pace and estimated to reach
to a three digit (in USD million) market size globally at a CAGR of double
digits.

The rapid
increase in the number of diabetes patients is the major driving force for the
estimated growth. The most important driver for the CGM market in Europe is the
need for a convenient, affordable, and patient-friendly device that facilitates
superior therapy management for diabetes and this need can be fulfilled by CGM
devices. In the present scenario, the slow growth rate of the market in the
Asian region is due to the late launch of CGM systems and a slow acceptance of
these systems in low and middle income nations such as China and India due to
the unaffordable price. In Japan and Australia, various regulatory approvals
are a hindrance for the growth of the market.

Some of the market players in this industry include
Medtronic Inc., DexCom Inc., Abbott Diabetes Care Inc and others.

This research report analyzes this market depending on
its market segments, major geographies, and current market trends. Geographies
analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World

This report provides comprehensive analysis
of

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

This report is a complete study of current trends in
the market, industry growth drivers, and restraints. It provides market
projections for the coming years. It includes analysis of recent developments
in technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed
value chain analysis.

Competition among CSPs (Communication service
providers) is bringing in new growth prospects for OSS/BSS software vendors.
Telecom companies are increasingly seeking software development services from
IT firms or are outsourcing their technological divisions for various service
systems. OSS/BSS software is used by telecom companies as back-end system for
smooth operations and integrated management of different sub-divisions. Driven
by combined impact of rise in consumer base, increase in amount of data
required to be managed, and expansion in customer oriented services, the
OSS/BSS market is expected to grow substantially worldwide.

Traditionally, CSPs relied on in-house developed
software systems for managing their different operational activities. However,
with fast emergence of new generation services and rise in customer base, the
scope of operations has multiplied manifolds. This has in turn created need for
CSPs to focus on their core services and outsource the others. Within the
telecom industry, OSS/BSS software is also referred to as B/OSS software.

However, it refers to Operations Support Systems (OSS)
and Business Support Systems (BSS) OSS software solutions include back office
support systems required for operating network and provisioning customer
services, such as inventory, designing, activation, and service assurance. The
BSS software solutions include customer interface services such as billing, CRM
(customer relationship management), order management, and others. There is push
from CSPs for integrated OSS and BSS software solutions as it would help them
to achieve higher operational efficacy.

Globally, Asia Pacific region, which has a huge and
fast rising customer base, is the key market for telecom industry players
looking for lucrative opportunities. Here, CSPs are competing aggressively to
acquire large consumer base as revenues from services are crunching and large
scale deployment is the key to success. As a result, there is a continuous need
for hardware upgrades which can meet the requirements posed by rising consumer
base and demands.

Another significant factor pushing the market demand up
for OSS/BSS software is the shift by CSPs from technology driven services to
customer oriented services, such as VAS (Value added services), as a prominent
revenue segment. However, technological limitations faced in integrating B/OSS
solutions with existing infrastructure is deterring the move from CSPs, who are
already facing challenges in reducing operation cost while meeting the
alleviated revenue targets. Consequently, this is giving rise to demand for
customized B/OSS software solutions. The most desired feature is flexibility to
expand capacity and accommodate operational changes.

Regionally, markets such as India and North Africa hold
long term growth potential for B/OSS software service providers having stake in
the market. Some of the players currently providing OSS/BSS software solutions
include IBM, Alcatel Lucent, Nokia Siemens Networks, Huawei, Oracle Corp.,
Amdocs, Subex, Elitecore Technologies, and others. Driven by perceived benefits
and growth opportunities there is a surge in new players entering the market
making the space saturated. This is in turn driving the competition levels
high, bringing in improved services for customers at competitive prices, and
thus supporting the market growth. The growth trend is expected to remain so in
near future as CSPs in emerging economies switch to new generation
technologies.

This report is a complete study of current trends in
the market, industry growth drivers, and restraints. It provides market
projections for the coming years. It includes analysis of recent developments
in technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed value
chain analysis.

This research report analyzes this market depending on
its market segments, major geographies, and current market trends. Geographies
analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World

This report provides comprehensive analysis
of

Market growth
drivers

Factors limiting market
growth

Current market
trends

Market structure

Market projections for
upcoming years

This report is a complete study of current trends in
the market, industry growth drivers, and restraints. It provides market
projections for the coming years. It includes analysis of recent developments
in technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed
value chain analysis.

Growing focus of the seed
industry on crop protection is leading to development of different seed
treatment methods. The growing seed market is the key driver for seed
treatment. In addition, higher prices of seeds and technological development in
seed treatment methods are also leading to significant growth in demand for
seed treatment.

This report analyzes
estimates and forecasts the global market of seed treatment in terms of revenue
and also analyzes major driving and restraining factors for the market. In
addition, the study includes opportunities for the seed treatment market in the
near future.

The study includes
analysis of global demand for seed treatment in terms of revenue from 2011 to
2018. The study further segments the market on the basis of treatment type and
crop type and analyzes the demand for each segment from 2011 to 2018. The
report also includes analysis and estimates of seed treatment demand for the
main geographical regions backed by analysis for major countries.

The study includes value
chain analysis to give a comprehensive view of major players in the seed treatment
market. The study also analyzes market competition using Porter’s Five Force
Model and analyzes impact of suppliers, buyers, substitutes, new entrants and
market competition. The study includes company market share analysis for the
major players operating in the seed treatment market. Syngenta, Monsanto, Bayer
CropScience, BASF, DuPont, Chemutra Inc. and Nufarm are some of the company
profiles included in the report.

Feed antioxidants are primarily used to increase the
shelf life of the feed by protecting it from oxidation, thus ensuring feed
quality and safety. The market is witnessing growth due to rise in global meat
consumption and increasing concerns regarding the health of the animals. This
study provides a strategic analysis of the global animal feed antioxidants
market in terms of volume as well as revenue estimated from 2012 and forecasted
till 2018.

The study on animal feed antioxidants is sub categorized by livestock,
by product type and by geography in terms of both volume as well as revenue. By
product type it includes synthetic and natural antioxidants and by livestock it
is segmented as pork/swine, poultry, cattle, aquaculture and others.

The study interprets and analyzes the current market
drivers and trends of the global animal feed antioxidants market along with
risk and opportunities available for market growth. The study also provides
competitive analyses which covers company market share of major players, value
chain and market attractiveness. In addition, the study also includes current
and emerging applications of antioxidants in animal feed. It provides the
Porters five forces model, defining the bargaining power of buyers and
suppliers, threat from new substitutes and entrants, and highlighting the
degree of competition.

The study also includes company profiles of the major
participants of the market along with their financial overview, business
strategy and recent developments. Some of the major players profiled in this
study include BASF SE, CHR.Hansen, AB Vista, Alltech, Novozymes and DSM.

Antipsychotics are drugs used in the treatment of brain disorders such as
schizophrenia, bipolar disorder, and severe depression. According to the New
York Times, antipsychotics are one of the largest types of prescribed drugs in
the United States with over 3.1 million Americans accounting for a market worth
USD 18 billion in 2011 itself. Global estimates suggest that over 1.25% of the
global population suffers from psychosis and related disorders. This brings a
market of about 7.5 million people suffering from combined disorders of
schizophrenia, bipolar disorder, dementia, depression among other rare
conditions.

Several recent
studies have suggested instances of drug abuse and over prescription of these
drugs in the market, particularly in North America. Clinical studies have shown
severe drawbacks and addiction to antipsychotic drugs. A serious side effect
observed is tardive dyskinesia which is a potentially irreversible movement
disorder. These drugs are prescribed for mild symptoms as well, increasing the
market for the drugs tremendously.

Antipsychotics market is expected to increase with
increasing incidences of Schizophrenia and a very large market of clinical
depression. Certain drugs such as Ablify and Seroquel are the topmost in the
segment due to their advantage of reduced risk of side-effects. 2012 has
observed the end of the several drug patents and it is expected that generic
drugs will compete strongly in the market in the coming years. There is an
increasing general call in the medical community for adoption of a stronger
control while administering these drugs in the coming years.

This research report analyzes this market depending on
its market segments, major geographies, and current market trends. Geographies
analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World

This report provides comprehensive analysis
of

Market growth
drivers

Factors limiting market
growth

Current market
trends

Market structure

Market projections for
upcoming years

This report is a complete study of current trends in
the market, industry growth drivers, and restraints. It provides market
projections for the coming years. It includes analysis of recent developments
in technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed
value chain analysis.

Biochips are miniaturized
laboratories that can perform thousands of biochemical reactions such as polymerase
chain reaction (PCR) simultaneously and are used for a variety of purposes
ranging from disease diagnosis to detection of bioterrorism agents. This report
estimates the U.S. market for biochips in terms of revenue (USD million) for
the period 2012 to 2018, considering 2011 as the base year.

The biochip market is segmented
into products market and services market. The biochip market by products is
sub-segmented into three types, namely, microarrays, reagents and other
products including biochip instruments and software. The biochip products and
services market by application is sub-segmented into drug discovery, life
science research, IVD testing and other applications including disease
management, forensic medicines, drug-of-abuse testing and military and defense
applications.

The report provides an analysis
of market dynamics, which includes drivers, restraints and opportunities for
the biochip market in the U.S. It also analyses the internal and external
market factors and their effect on the ecosystem of the biochip market, with
the help of Porter’s five force analysis.

The report includes company
profiles of key market players such as Affymetrix, Inc., Life Technologies
Corporation, Illumina, Inc. and others. Profiles for all market players have
been provided based on parameters such as company overview, financial overview,
product portfolio, business strategies and recent developments.

The fish oil market includes
fish oil obtained from fishing as well as aquaculture. In terms of application,
this report analysis the primary uses of fish oil such as aquaculture, direct
human consumption (DHC) and industrial. Peru, Chile and Denmark were the
leading producers of fish oil and account for over 50% of production. In terms
of consumption, the European region was the largest consumer primarily due to
the farming of salmons and trout.

The report comprises a detailed
description on the forecast and analysis of the fish oil market on a global
level. The forecasted demand is based on volumes (kilo tons) and revenue (USD
million) for the period ranging from 2012 to 2018. The study consists of
drivers and restraints of the fish oil market and their impact on the growth of
the market within the forecast period. In addition, the study includes
opportunities available for the fish oil market on a global level.

For better understanding of the
fish oil market, we have given a detailed analysis of the value chain. In
addition, a comprehensive study of the Porters five forces model has been
provided for better understanding of the intensity of competition present in
the fish oil market. Furthermore, the study comprises a market attractiveness
analysis, where the applications are benchmarked based on their market size,
growth rate and general attractiveness.

The fish oil market has been
segmented based on its application and geography and each segment is forecast
in terms of volume (kilo tons) and revenue (USD million). All application
segments have been analyzed based on present and future trends and are forecast
over a period from 2012 to 2018. Geographically, the market has been segmented
into North America, Latin America, Europe, Asia Pacific and Rest of the World.
Analysis and forecast are based on current trends and ranging over a period of
six years, from 2012 to 2018.

Detailed profiles of certain
leading fish oil producers are covered in this report along with thorough
analysis of their market share. The renowned companies have been profiled with
respect to attributes such as company overview, financial overview, SWOT
analysis, business strategy and recent developments.

Search This Blog

About Me

The dedicated team of researchers and analysts at Business Research Industry into the Advantage of Knowledge for your company. Data becomes knowledge through the application of Dolcera's optimization process as follows.